Actinium Pharmaceuticals, Inc.

ATNM · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$72,904$76,677$108,910$77,829
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,602$1,586$2,032$1,920
Total Curr. Assets$74,506$78,263$110,942$79,749
Property Plant & Equip (Net)$2,069$2,869$2,948$639
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$324$313$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$302$0
Total NC Assets$2,393$3,182$3,250$639
Other Assets$0$0$0$0
Total Assets$76,899$81,445$114,192$80,388
Liabilities
Payables$7,568$7,953$10,130$5,535
Short-Term Debt$580$541$498$307
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$0$0$0$998
Total Curr. Liab.$8,148$8,494$10,628$6,840
LT Debt$993$1,572$2,083$3
Deferred Rev, NC$35,000$35,000$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$35,000$0
Total NC Liab.$35,993$36,572$37,083$3
Other Liabilities$0$0$0$0
Cap. Leases$1,573$1,572$2,581$310
Total Liabilities$44,141$45,066$47,711$6,843
Equity
Pref Stock$0$0$0$0
Common Stock$31$28$26$22
Retained Earnings-$375,826-$337,583-$288,765-$255,748
AOCI$0$0-$0-$0
Other Equity$408,553$373,934$355,220$329,271
Total Equity$32,758$36,379$66,481$73,545
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$76,899$81,445$114,192$80,388
Net Debt-$71,331-$74,564-$106,329-$77,519